1. Home
  2. NOTV vs NUKK Comparison

NOTV vs NUKK Comparison

Compare NOTV & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • NUKK
  • Stock Information
  • Founded
  • NOTV 1974
  • NUKK 2013
  • Country
  • NOTV United States
  • NUKK United States
  • Employees
  • NOTV N/A
  • NUKK N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • NUKK Blank Checks
  • Sector
  • NOTV Health Care
  • NUKK Finance
  • Exchange
  • NOTV Nasdaq
  • NUKK Nasdaq
  • Market Cap
  • NOTV 46.7M
  • NUKK 37.7M
  • IPO Year
  • NOTV 1997
  • NUKK N/A
  • Fundamental
  • Price
  • NOTV $1.39
  • NUKK $8.30
  • Analyst Decision
  • NOTV Strong Buy
  • NUKK
  • Analyst Count
  • NOTV 1
  • NUKK 0
  • Target Price
  • NOTV $5.00
  • NUKK N/A
  • AVG Volume (30 Days)
  • NOTV 446.2K
  • NUKK 3.5M
  • Earning Date
  • NOTV 08-06-2025
  • NUKK 11-14-2025
  • Dividend Yield
  • NOTV N/A
  • NUKK N/A
  • EPS Growth
  • NOTV N/A
  • NUKK N/A
  • EPS
  • NOTV N/A
  • NUKK N/A
  • Revenue
  • NOTV $505,299,000.00
  • NUKK N/A
  • Revenue This Year
  • NOTV $5.64
  • NUKK N/A
  • Revenue Next Year
  • NOTV $5.16
  • NUKK N/A
  • P/E Ratio
  • NOTV N/A
  • NUKK N/A
  • Revenue Growth
  • NOTV 0.85
  • NUKK N/A
  • 52 Week Low
  • NOTV $1.15
  • NUKK $1.30
  • 52 Week High
  • NOTV $6.48
  • NUKK $78.32
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 42.19
  • NUKK 65.86
  • Support Level
  • NOTV $1.41
  • NUKK $5.18
  • Resistance Level
  • NOTV $1.57
  • NUKK $9.70
  • Average True Range (ATR)
  • NOTV 0.12
  • NUKK 0.93
  • MACD
  • NOTV 0.02
  • NUKK 0.34
  • Stochastic Oscillator
  • NOTV 31.19
  • NUKK 71.26

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).

Share on Social Networks: